Bryan J. Bonder
Expertise in
4
conditions

Dr. Bryan J. Bonder

Hematology Oncology
6780 Mayfield Road, 
Mayfield Hts, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
4
conditions
6780 Mayfield Road, 
Mayfield Hts, OH 

Overview

Bryan Bonder is a Hematologist Oncology provider practicing medicine in Mayfield Hts, Ohio.

Dr. Bonder is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Anemia.

Dr. Bonder is board certified in American Board Of Internal Medicine, 2022. He is actively involved in clinical research, participating in 3 clinical trials. Dr. Bonder is currently accepting new patients.

Specialties

Hematology Oncology

Board Certifications

American Board Of Internal Medicine, 2022

Fellowships

Case Western Reserve University/University Hospitals Case Medical Center

Hospital Affiliations

Akron General Medical Center
Euclid Hospital
Cleveland Clinic
South Pointe Hospital
Hillcrest Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Hillcrest Hospital
6780 Mayfield Road, Mayfield Hts, OH 44124
Other Locations
Twinsburg Family Health and Surgery Center
8701 Darrow Road, Twinsburg, OH 44087

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Enrollment Status: Recruiting
Publish Date: July 30, 2026
Intervention Type: Drug, Radiation, Biological
Study Drugs: Temozolomide, Lomustine, Regorafenib, Paxalisib, VAL-083
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Completed
Publish Date: April 22, 2026
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
Genomically-Guided Treatment Trial in Brain Metastases
Genomically-Guided Treatment Trial in Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Paxalisib, Entrectinib
Study Phase: Phase 2
View 2 Less Clinical Trial
Similar Doctors
Expertise in
60
conditions
Dr. Joel N. Saltzman
Hematology Oncology
Expertise in
60
conditions
Dr. Joel N. Saltzman
Hematology Oncology
Referral may be required
Before you request

Hillcrest Hospital

6780 Mayfield Road, 
Mayfield Hts, OH 
 (0.1 miles away)
440-312-4500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joel Saltzman is a Hematologist Oncology provider practicing medicine in Mayfield Hts, Ohio. Dr. Saltzman is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lynch Syndrome, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Saltzman is board certified in American Board Of Internal Medicine, 2004. Dr. Saltzman is currently accepting new patients.

Expertise in
71
conditions
Dr. Omer N. Koc
Hematology Oncology
Expertise in
71
conditions
Dr. Omer N. Koc
Hematology Oncology
Referral may be required
Before you request

Beachwood Family Health Center

26900 Cedar Rd, 
Beachwood, OH 
 (3.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Omer Koc is a Hematologist Oncology provider practicing medicine in Beachwood, Ohio. Dr. Koc is highly rated in 71 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mycosis Fungoides, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Koc is board certified in American Board Of Internal Medicine, 1996. Dr. Koc is currently accepting new patients.

Expertise in
40
conditions
Dr. Vitaliy I. Pishchik
Hematology Oncology
Expertise in
40
conditions
Dr. Vitaliy I. Pishchik
Hematology Oncology
Referral may be required
Before you request

Hillcrest Hospital

6780 Mayfield Road, 
Mayfield Hts, OH 
 (0.1 miles away)
440-312-4500
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Vitaliy Pishchik is a Hematologist Oncology provider practicing medicine in Mayfield Hts, Ohio. Dr. Pishchik is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Cor Pulmonale, Childhood Iron Deficiency Anemia, Urothelial Cancer, Muscle Invasive Bladder Cancer, and Bone Marrow Aspiration. Dr. Pishchik is board certified in American Board Of Internal Medicine, 2014. Dr. Pishchik is currently accepting new patients.

Expertise in
15
conditions
Dr. Neha Mitra
Hematology Oncology
Expertise in
15
conditions
Dr. Neha Mitra
Hematology Oncology
Referral may be required
Before you request

Hillcrest Hospital

6780 Mayfield Rd, 
Mayfield Heights, OH 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Neha Mitra is a Hematologist Oncology provider practicing medicine in Mayfield Heights, Ohio. Dr. Mitra is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Mitra is board certified in American Board Of Internal Medicine, 2012. Dr. Mitra is currently accepting new patients.

Expertise in
55
conditions
Dr. Aric W. Greenfield
Hematology Oncology
Expertise in
55
conditions
Dr. Aric W. Greenfield
Hematology Oncology
Referral may be required
Before you request

Willoughby Hills Family Health Center

2570 Som Center Rd, 
Willoughby Hills, OH 
 (5.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Aric Greenfield is a Hematologist Oncology provider practicing medicine in Willoughby Hills, Ohio. Dr. Greenfield is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Paget Disease of the Breast, Breast Cancer, and Hodgkin Lymphoma. Dr. Greenfield is board certified in American Board Of Internal Medicine, 1984. Dr. Greenfield is currently accepting new patients.

Expertise in
31
conditions
Dr. Samir Abraksia
Hematology Oncology
Expertise in
31
conditions
Dr. Samir Abraksia
Hematology Oncology
Referral may be required
Before you request

South Pointe Medical Office Building B

20050 Harvard Avenue, 
Warrensville Heights, OH 
 (7.2 miles away)
216-491-6000
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Samir Abraksia is a Hematologist Oncology provider practicing medicine in Warrensville Heights, Ohio. Dr. Abraksia is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, and Congenital Antithrombin 3 Deficiency. Dr. Abraksia is board certified in American Board Of Internal Medicine, 1997. Dr. Abraksia is currently accepting new patients.

Frequently Asked Questions about Dr. Bryan J. Bonder

How do I make an appointment with Dr. Bryan J. Bonder?

You can book an appointment with Dr. Bryan J. Bonder by calling their office at 440-312-4500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bryan J. Bonder a top-rated expert for Posterior Fossa Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bryan J. Bonder is classified as an Distinguished expert for Posterior Fossa Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bryan J. Bonder specialize in?

While Dr. Bryan J. Bonder is a Hematology Oncology, they have specific expertise in Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Metastatic Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Bryan J. Bonder accept my insurance?

Dr. Bryan J. Bonder accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 440-312-4500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bonder's expertise for a condition
ConditionClose
    View All 66 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile